Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Universidade Tiradentes (Unit) is a prominent private higher education and research institution in Brazil, recognized for its significant contributions to the life sciences and biotechnology sectors. Through its Institute for Technology and Research (ITP), the university conducts advanced R&D in areas such as nanomedicine, industrial biotechnology, and the pharmacology of natural products. Unit is particularly noted for its postgraduate programs in Industrial Biotechnology and Health and Environment, which aim to bridge the gap between academic research and industrial application. The institution focuses on developing innovative drug delivery systems, such as solid lipid nanoparticles, and exploring the therapeutic potential of Brazilian biodiversity. As a key player in the regional innovation ecosystem, Unit collaborates with both public and private sectors to advance healthcare technologies and bioprocessing solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Universidade Tiradentes.